Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?

Nature reviews. Rheumatology - 1 Mar 2011

Verweij Cornelis L

Abstract excerpt

A substantial proportion of patients with rheumatoid arthritis do not respond to tumor necrosis factor blocking therapy. Results of a large genome-wide association study demonstrate evidence of novel genetic factors that determine response to treatment, which could provide a basis for individualizing therapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Arthritis, Rheumatoid
Share to Cell Adhesion Molecules

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Pharmacogenetics

Share to Precision Medicine

Share to Trans-Activators

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 21304506
DOI: 10.1038/nrrheum.2011.13

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?PMID 21304506Read ↗

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy.Semantic proximity Read ↗

Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Semantic proximity Read ↗

Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directionsSemantic proximity Read ↗

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.Semantic proximity Read ↗

Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis.Semantic proximity Read ↗

Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries.Semantic proximity Read ↗

Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.Semantic proximity Read ↗

Genetic and genomic predictors of anti-TNF response.Semantic proximity Read ↗

Pharmacogenetics in treatment of rheumatoid arthritis.Semantic proximity Read ↗

Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.Semantic proximity Read ↗

Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.